InVera Medical announced 12-month results from its pilot clinical study of the InVera infusion device for the treatment of ...
InVera Medical, a medical device company focused on advancing minimally-invasive technologies for Chronic Venous Disease, ...
TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, is ...
The VENUS trial results, which demonstrated a benefit of adding an ethanol infusion to the vein of Marshall during catheter ablation of persistent atrial fibrillation (AF), are now published. The ...
MANHATTAN, Kan. (WIBW) - The out-patient clinic at Ascension Via Christi in Manhattan treated seven patients Thursday with COVID-19 antibody infusions, in hopes to reduce the severity of symptoms.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results